![[Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier].](https://cdn.physiciansweekly.com/wp-content/uploads/2020/12/cancer-cell.jpg)
A 69-year-old man was diagnosed with diffuse large B-cell lymphoma (DLBCL) negative for...
Read More
Oral and gum health have long been associated with incidence and outcomes of cardiovascular...
Read More
Chimeric antigen receptors T (CAR-T) cell therapy of cancer is a rapidly evolving field. It has...
Read More
Renal cell carcinoma (RCC) is known to respond to immune checkpoint blockade (ICB) therapy,...
Read More
We conducted a survey to investigate the prevalence and factors associated with anxiety and...
Read More
Relapsed/refractory peripheral T cell-lymphomas (PTCL) have a poor prognosis. We aimed at...
Read More
Aberrant B-cell receptor (BCR)/NF-kB signaling is a hallmark feature of B-cell non-Hodgkin...
Read More
We sought to validate levels of CD8 tumor-infiltrating cells (TIC) expressing PD-1 but not TIM-3...
Read More
Chimeric antigen receptor (CAR) T-cell therapies are currently administered at a limited number of...
Read More
The following is a summary of “Telemedicine virologic and immunologic outcomes in people living...
Read More
The following is a summary of “Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to...
Read More
A review of treatments for TP53m MCL found high response rates with targeted and CAR-T therapies but highlighted poor survival, urging innovative strategies.
Read More
The following is a summary of “Association of CD19+-Targeted Chimeric Antigen Receptor (CAR)...
Read More
The following is a summary of “Identification of host endotypes using peripheral blood...
Read More
1. The median progression-free survival in the metastasis-directed therapy arm was 10.3 months vs...
Read MoreIn the Physician’s Weekly (PW) podcast’s first episode of 2024, host Rachel Giles, MD, and PW editorial board member Alex McDonald, MD, discussed their perspectives on anticipated medical breakthroughs they felt could shape the...
Read More
The following is a summary of “Exosome-mediated Delivery of miR-519e-5p Promotes Malignant...
Read MoreOral squamous cell carcinoma (OSCC) is a malignant tumor with a poor prognosis. Traditional treatments have limited effectiveness. Regulation of the immune response represents a promising new approach for OSCC treatment. B cells...
Read More
The following is a summary of “Liquid Biopsy in T-cell Lymphoma: Biomarker Detection Techniques...
Read MoreBACKGROUND Idiopathic giant cell myocarditis (IGCM) is an uncommon and frequently fatal type of myocarditis. It primarily affects young individuals and has the potential to result in heart failure and life-threatening...
Read More
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
